The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues including medicines regulation, UK and EU trading relationships, access to talent, and the future of UK science.
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.
Medicines and vaccines have helped deliver incredible improvements in patient health. This section looks at expenditure on R&D in the UK and around the world.
The UK is a world leader in medical research and innovation, built on the foundation of collaborations between industry and academia throughout Britain.
Discover events for both members and non-members as well as speaking engagements of senior ABPI leadership.
As a membership organisation we work with our member companies, and the expertise of the specialists they employ, to develop and present our points of view to UK and European governments, the public and to other stakeholders.
05 Jan 2018 An open letter to: the BMJ
16 Jan 2018 Preparing for Brexit: ABPI’s reaction to MHRA update for pharma
18 Jan 2018 AMR Industry Alliance launches first report into Industry's AMR action globally
25 Jan 2018 Professor Carole Longson MBE appointed Chief Scientific Officer at the ABPI
28 Jan 2018 Patients must get the medicine they need after Brexit
23 Feb 2018 Response to announcement of Baroness Cumberlege's review into patient safety
27 Feb 2018 Response to consultation on the Cost-Effectiveness Methodology for Vaccination Programmes and Procurement (CEMIPP)
01 Mar 2018 New UK-wide agreement (mCTA) to speed up clinical trials and medicines R&D
02 Mar 2018 The pharmaceutical industry response to the Prime Minister’s 'Road to Brexit' speech
08 Mar 2018 ABPI launches lesson plan to encourage more girls into a career in STEM
21 Mar 2018 Industry backs findings of new Health and Social Care Committee report into Brexit
23 Mar 2018 UK pharma welcomes positive progression in Brexit talks
03 Apr 2018 ABPI responds to The Times investigation into industry payments
18 Apr 2018 Our view: Redistribution of UK’s portfolio of centrally authorised products
19 Apr 2018 New verification system will secure patient safety and support continuation of medicines supply
24 Apr 2018 Regardless of age, gender, geography and politics, Brits say: “We’ll personally step up to help the NHS fight the diseases of the future”
25 Apr 2018 Sci-Fi or reality? New Virtual Reality experience explores the next 70 years of science and medicine
26 Apr 2018 ABPI responds to Kings Fund report into the cost of medicines for the NHS
26 Apr 2018 ABPI response to the House of Lords Science and Technology Committee report
26 Apr 2018 Lisa Anson speech to the ABPI Annual Conference 2018
26 Apr 2018 Mike Thompson speech to the ABPI Annual Conference 2018
17 May 2018 Life Sciences sector responds to BEIS Committee report on the impact of Brexit on the pharmaceutical sector
21 May 2018 ABPI responds to PM speech on plans to transform outcomes for people with chronic diseases
22 May 2018 ABPI response to Government commitment of £30 million to fight global antimicrobial resistance (AMR)
07 Jun 2018 Our response to the European Commission's Horizon EU announcement
15 Jun 2018 New £56 million investment in Scotland to transform the UK's place in the global pharma industry
17 Jun 2018 ABPI response to NHS funding announcement
20 Jun 2018 Apprenticeships hit 4-year high in pharmaceutical industry
25 Jun 2018 Update: Astellas UK
29 Jun 2018 Pharmaceutical industry continues to invest significantly in UK research and development
29 Jun 2018 Joint ABPI/BIA comment on EU Council Meeting
02 Jul 2018 Industry response to Simon Stevens’ comments on the Andrew Marr show
06 Jul 2018 Pharmaceutical industry and NHS working together to transform patient care, priority for new ABPI President
08 Jul 2018 ABPI reaction to Prime Minister's Chequers statement
11 Jul 2018 ABPI response to European Medicines Agency survey
12 Jul 2018 Pharmaceutical industry reaction to Brexit White Paper